Picture of HTG Molecular Diagnostics logo

HTGMQ HTG Molecular Diagnostics Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m-71.21%
3m+4.77%
6m-99.55%
1yr-99.96%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-99.97%
50d MA-82.74%
200d MA-99.81%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-454.8%
Return on Equity-343.21%
Operating Margin-315.21%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of HTG Molecular Diagnostics EPS forecast chart

Profile Summary

HTG Molecular Diagnostics, Inc. is a life science company. The Company is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The Company is engaged in the sales of its HTG EdgeSeq system and integrated next-generation sequencing-based (NGS-based) HTG EdgeSeq research use only (RUO) assays and from sample processing services. Its HTG EdgeSeq profiling technology measures ribonucleic acid (RNA) using deoxyribonucleic acid (DNA) nuclease protection probes (DNA protection probes). Its profiling product and service solutions enable targeted RNA profiling using a small amount of biological sample, in liquid or solid forms. Its menu of HTG EdgeSeq assays includes the HTG Transcriptome Panel (HTP), which is designed to measure approximately 20,000 mRNA targets using its HTG EdgeSeq technology, is automated on its HTG EdgeSeq system.

Directors

Last Annual
December 31st, 2022
Last Interim
March 31st, 2023
Incorporated
December 14th, 2000
Public Since
May 6th, 2015
No. of Shareholders
57
No. of Employees
53
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconPink Sheets on Nasdaq
Shares in Issue
2,214,233

HTGMQ Share Price Performance

Upcoming Events for HTGMQ

Q4 2023 HTG Molecular Diagnostics Inc Earnings Release

Q1 2024 HTG Molecular Diagnostics Inc Earnings Release

Similar to HTGMQ

Picture of Aamaxan Transport logo

Aamaxan Transport

us flag iconPink Sheets on Nasdaq

Picture of ACCUSTEM SCIENCES logo

ACCUSTEM SCIENCES

us flag iconPink Sheets on Nasdaq

Picture of ADM Tronics Unlimited logo

ADM Tronics Unlimited

us flag iconPink Sheets on Nasdaq

Picture of Aksys logo

Aksys

us flag iconPink Sheets on Nasdaq

FAQ